HedgeChatter

  • Home /
  • Tag Archives

AEGR

Aegerion Pharmaceuticals Announces Fourth-Quarter and Full-Year 2013 Financial Results

[GlobeNewswire] – — Company Achieves 2013 Net Product Sales of $48.5 Million — 2014 Net Product Sales Expected to be Between $190 and $210 Million — Cash Flow Positive Operations Anticipated in the Second Half of 2014… moreView todays social media effects on AEGRView the latest stocks trending across Twitter. Click to view dashboardSee who Aegerion is hiring next, click […]

February 26, 2014 Bystocknews , Comments Off on Aegerion Pharmaceuticals Announces Fourth-Quarter and Full-Year 2013 Financial Results read more

AEGERION PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Against Aegerion Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of March 17, 2014 — AEGR

[PR Newswire] – NEW YORK, Feb. 25, 2014 /PRNewswire/ — Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Massachusetts on behalf of investors … moreView todays social media effects on AEGRView the latest stocks trending across Twitter. Click to view dashboardSee who Aegerion is hiring next, […]

February 25, 2014 Bystocknews , Comments Off on AEGERION PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Against Aegerion Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of March 17, 2014 — AEGR read more

Hagens Berman Advises Investors of March 17, 2014, Deadline in Aegerion Pharmaceuticals, Inc. Securities Lawsuit and Investigation

[Business Wire] – Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, is investigating Aegerion Pharmaceuticals, Inc. for securities fraud following the news that the company illegally engaged in off-label marketing schemes and advises moreView todays social media effects on AEGRView the latest stocks trending across Twitter. Click to view dashboardSee who Aegerion is hiring next, click here […]

February 25, 2014 Bystocknews , Comments Off on Hagens Berman Advises Investors of March 17, 2014, Deadline in Aegerion Pharmaceuticals, Inc. Securities Lawsuit and Investigation read more

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Aegerion Pharmaceuticals, Inc. and Certain Officers – AEGR

[PR Newswire] – NEW YORK, Feb. 14, 2014 /PRNewswire/ — Pomerantz LLP has filed a class action lawsuit against Aegerion Pharmaceuticals, Inc. (Aegerion or the Company)(AEGR) and certain of its officers. The class action, filed in United States District C moreView todays social media effects on AEGRView the latest stocks trending across Twitter. Click to view dashboardSee who Aegerion is […]

February 14, 2014 Bystocknews , Comments Off on SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Aegerion Pharmaceuticals, Inc. and Certain Officers – AEGR read more

Aegerion Pharmaceuticals to Announce Fourth-Quarter and Full-Year 2013 Financial Results on Wednesday, February 26

[GlobeNewswire] – CAMBRIDGE, Mass. — Aegerion Pharmaceuticals, Inc. , a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases, … moreView todays social media effects on AEGRView the latest stocks trending across Twitter. Click to view dashboardSee who Aegerion is hiring next, click here to view […]

February 13, 2014 Bystocknews , Comments Off on Aegerion Pharmaceuticals to Announce Fourth-Quarter and Full-Year 2013 Financial Results on Wednesday, February 26 read more